出血性中风的个体触发因素:来自案例交叉和自我控制案例系列研究的证据
Junyu Liu1,2, Chun Luo3, Yuxin Guo3
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
European stroke journal
|August 29, 2023
概括
鉴定出血性中风 (HS) 的触发因素对于预防至关重要. 这项研究发现,药物,感染,疫苗接种和身体炼和愤怒等行为可以触发HS,而药物使用和吸烟没有显示相关性.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 由于高死亡率和残疾率,出血性中风 (HS) 构成了重大挑战.
- 了解个别触发因素对于制定有效的HS预防和干预策略至关重要.
研究的目的:
- 系统地分析与出血性中风 (HS) 相关的个别触发因素.
- 通过确定关键触发因素,为HS的预防和干预提供科学基础.
主要方法:
- 在五个数据库中进行了系统的文献搜索,截至2022年12月.
- 包括使用案例交叉或自我控制案例系列设计的研究.
- 对已识别的HS触发因素进行了描述性摘要和证据综合.
主要成果:
- 对39项研究的分析确定了HS的32个潜在触发类别.
- 对抗凝血药物,感染,接种疫苗,体力活动,可乐饮料消费,性活动,吹鼻子,排便和愤怒发现了显著的关联.
- 在非法药物使用或吸烟与HS发病之间没有观察到任何显著的关联.
结论:
- 个人因素,如药物,感染,疫苗接种和特定的行为可以导致HS.
- 通过直接控制措施准行为触发器是关键的预防策略.
- 为高风险人群推个性化监测和治疗,以平衡HS风险与潜在疾病.
相关概念视频
Disorders of Hemostasis
989
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
989
Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
Causality in Epidemiology
463
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
463
Criteria for Causality: Bradford Hill Criteria - II
363
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
363
Criteria for Causality: Bradford Hill Criteria - I
333
The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples:
333
Hazard Ratio
155
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
155


